枸橼酸与肝素在连续血液滤过中抗凝效果的比较(2)
 |
| 第1页 |
参见附件(2462KB，2页)。
参考文献
[1] Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int, 1993,4:S237-S244
[2] Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Continuous is not continuous: the incidence and impact of circuit “downtime” on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med, 2003,29: 575-578
[3] Cutts MW, Thomas AN, Kishen R: Transfusion requirements during continuous veno-venous haemofiltration: the importance of filter life. Intensive Care Med,2000, 26:1694-1697
[4] Oudemans-Van Straaten HM: Anticoagulation for renal replacement therapy: heparin or citrate. In Controversies in Intensive Care Medicine. Edited by Kuhlen R, Moreno R, Ranieri M, Rhodes A. Berlin: Medizinische Wissenschaftliche Verlagsgesellschaft; 2008:153-161
[5] Oudemans-Van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI Dijksman LM, Zandstra DF: Citrate anticoagulation for continuous venovenous hemofi ltration. Crit Care Med 2009, 37:545-552
[6] Carr JA, Silverman N: The heparin-protamine interaction. A review. J Cardiovasc Surg (Torino) 1999, 40:659-666
您现在查看是摘要介绍页，详见PDF附件(2462KB，2页)。